These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 26671705)

  • 1. Healthcare service utilisation costs attributable to rheumatoid arthritis in France: Analysis of a representative national claims database.
    Fautrel B; Cukierman G; Joubert JM; Laurendeau C; Gourmelen J; Fagnani F
    Joint Bone Spine; 2016 Jan; 83(1):53-6. PubMed ID: 26671705
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Burden of severe spondyloarthritis in France: A nationwide assessment of prevalence, associated comorbidities and cost.
    Claudepierre P; Fagnani F; Cukierman G; de Chalus T; Joubert JM; Laurendeau C; Gourmelen J; Breban M
    Joint Bone Spine; 2019 Jan; 86(1):69-75. PubMed ID: 29709699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costs of rheumatoid arthritis in Germany: a micro-costing approach based on healthcare payer's data sources.
    Ruof J; Hülsemann JL; Mittendorf T; Handelmann S; von der Schulenburg JM; Zeidler H; Merkesdal S
    Ann Rheum Dis; 2003 Jun; 62(6):544-9. PubMed ID: 12759292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Migraine burden and costs in France: a nationwide claims database analysis of triptan users.
    Donnet A; Emery C; Aly S; Allaf B; Cayre F; Mahieu N; Gourmelen J; Levy P; Fagnani F
    J Med Econ; 2019 Jul; 22(7):616-624. PubMed ID: 30836035
    [No Abstract]   [Full Text] [Related]  

  • 5. Direct medical costs associated with rheumatoid arthritis in Turkey: analysis from National Claims Database.
    Baser O; Burkan A; Baser E; Koselerli R; Ertugay E; Altinbas A
    Rheumatol Int; 2013 Oct; 33(10):2577-84. PubMed ID: 23708559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Healthcare service utilisation costs are reduced when rheumatoid arthritis patients achieve sustained remission.
    Barnabe C; Thanh NX; Ohinmaa A; Homik J; Barr SG; Martin L; Maksymowych WP
    Ann Rheum Dis; 2013 Oct; 72(10):1664-8. PubMed ID: 23117244
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The national healthcare system claims databases in France, SNIIRAM and EGB: Powerful tools for pharmacoepidemiology.
    Bezin J; Duong M; Lassalle R; Droz C; Pariente A; Blin P; Moore N
    Pharmacoepidemiol Drug Saf; 2017 Aug; 26(8):954-962. PubMed ID: 28544284
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shifting Cost-drivers of Health Care Expenditures in Inflammatory Bowel Disease.
    Click B; Lopez R; Arrigain S; Schold J; Regueiro M; Rizk M
    Inflamm Bowel Dis; 2020 Jul; 26(8):1268-1275. PubMed ID: 31671186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct medical expenditure associated with rheumatoid arthritis in a nationally representative sample from the medical expenditure panel survey.
    Kawatkar AA; Jacobsen SJ; Levy GD; Medhekar SS; Venkatasubramaniam KV; Herrinton LJ
    Arthritis Care Res (Hoboken); 2012 Nov; 64(11):1649-56. PubMed ID: 22674912
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Medical costs for Korean patients with rheumatoid arthritis based on the national claims database.
    Kwon JM; Cho SK; Kim JH; Lee EK
    Rheumatol Int; 2012 Sep; 32(9):2893-9. PubMed ID: 21898062
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comorbidities in people living with HIV: An epidemiologic and economic analysis using a claims database in France.
    Pourcher V; Gourmelen J; Bureau I; Bouee S
    PLoS One; 2020; 15(12):e0243529. PubMed ID: 33332394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of bariatric surgery on the medical management and costs of obese patients in France: an analysis of a national representative claims database.
    Czernichow S; Moszkowicz D; Szwarcensztein K; Emery C; Lafuma A; Gourmelen J; Fagnani F
    Obes Surg; 2015 Jun; 25(6):986-96. PubMed ID: 25366293
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of outpatient reimbursement for interstitial cystitis/bladder pain syndrome and rheumatoid arthritis treatment in Taiwan: A nationwide population-based study.
    Lin HY; Lee MH; Chang KM; Wu HC
    Low Urin Tract Symptoms; 2019 Apr; 11(2):O162-O167. PubMed ID: 30073771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Economic burden of coronary artery disease or peripheral artery disease in patients at high risk of ischemic events in the French setting: a claims database analysis.
    Emery C; Torreton E; Briere JB; Evers T; Fagnani F
    J Med Econ; 2020 May; 23(5):513-520. PubMed ID: 31928390
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevalence and economic burden of cardiovascular diseases in France in 2013 according to the national health insurance scheme database.
    Tuppin P; Rivière S; Rigault A; Tala S; Drouin J; Pestel L; Denis P; Gastaldi-Ménager C; Gissot C; Juillière Y; Fagot-Campagna A
    Arch Cardiovasc Dis; 2016; 109(6-7):399-411. PubMed ID: 27079468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of medical practices on the costs of management of rheumatoid arthritis by anti-TNFalpha biological therapy in France.
    Fautrel B; Woronoff-Lemsi MC; Ethgen M; Fein E; Monnet P; Sibilia J; Wendling D
    Joint Bone Spine; 2005 Dec; 72(6):550-6. PubMed ID: 15996504
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hidden cost of rheumatoid arthritis (RA): estimating cost of comorbid cardiovascular disease and depression among patients with RA.
    Joyce AT; Smith P; Khandker R; Melin JM; Singh A
    J Rheumatol; 2009 Apr; 36(4):743-52. PubMed ID: 19228658
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is rheumatoid arthritis care more costly when provided by rheumatologists compared with generalists?
    Gabriel SE; Wagner JL; Zinsmeister AR; Scott CG; Luthra HS
    Arthritis Rheum; 2001 Jul; 44(7):1504-14. PubMed ID: 11465700
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economic burden of highly active relapsing-remitting multiple sclerosis patients in the French national health insurance database.
    Vandhuick O; Payet M; Préaud E; Lortet-Tieulent J; Raguideau F; Chevreuil O; van Hille B; Kwiatkowski A
    Expert Rev Pharmacoecon Outcomes Res; 2021 Oct; 21(5):1135-1144. PubMed ID: 34165377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nationwide population-based epidemiologic study of rheumatoid arthritis in Taiwan.
    Lai CH; Lai MS; Lai KL; Chen HH; Chiu YM
    Clin Exp Rheumatol; 2012; 30(3):358-63. PubMed ID: 22513120
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.